Published On:Apr 2018 Pages:100 Category: Emerging & Next Generation Technologies Report Code:SE04683
The Warm Edge Spacer Market has encountered significant development in the recent years and is foreseen to grow tremendously over the forecast period.
Published On:Apr 2018 Pages:80 Category: Pharmaceuticals Report Code:HC04682
The Hormonal Contraceptive Market was worth USD 13.24 billion in 2014 and is expected to reach approximately USD 15.60 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 1.84% during the forecast period.
Published On:Apr 2018 Pages:90 Category: Energy Report Code:EM04681
The Hybrid Solar Wind Energy Storage Market has witnessed substantial development and is anticipated to grow significantly over the forecast period
Published On:Apr 2018 Pages:90 Category: Advanced Materials Report Code:CM04680
The Molecular Sieves Market has encountered significant development in the recent years and is foreseen to develop tremendously over the forecast period.
Published On:Apr 2018 Pages:90 Category: Renewable Chemicals Report Code:CM04679
The Nanocellulose Market was worth USD 100.67 million in 2014 and is expected to reach approximately USD 483.58 million by 2023, while registering itself at a compound annual growth rate (CAGR) of 19.05% during the forecast period.
Published On:Apr 2018 Pages:120 Category: Pharmaceuticals Report Code:HC04678
Expanding prevalence of cancer and metabolic disorders, for example, obesity, diabetes, and osteoporosis are the key variables contributing toward the adoption of peptide therapeutics over the conjecture time frame.
Published On:Apr 2018 Pages:100 Category: Healthcare IT Report Code:HC04677
The Pharmacovigilance (PV) Market was worth USD 2.78 billion in 2014 and is expected to reach approximately USD 8.46 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 13.14% during the forecast period.
Published On:Apr 2018 Pages:90 Category: Biotechnology Report Code:HC04676
The Poultry Diagnostics Market was worth USD 0.25 million in 2014 and is expected to reach approximately USD 0.62 million by 2023, while registering itself at a compound annual growth rate (CAGR) of 10.45% during the forecast period.
Published On:Apr 2018 Pages:90 Category: Healthcare IT Report Code:HC04675
The Rare Hemophilia Factors Market was worth USD 0.23 million in 2014 and is expected to reach approximately USD 0.33 million by 2023, while registering itself at a compound annual growth rate (CAGR) of 4.06% during the forecast period.
Published On:Apr 2018 Pages:100 Category: Biotechnology Report Code:HC04674
The Rare Neurological Disease Treatment Market was worth USD 4.82 billion in 2014 and is expected to reach approximately USD 10.16 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 8.63% during the forecast period.
Published Date :2023-03-16
Published Date :2023-03-06
Published Date :2023-02-22
Published Date :2023-02-06
Published Date :2023-02-01
Published Date :2023-01-27
Published Date :2023-01-16
Published Date :2023-01-03
Published Date :2022-12-29
Published Date :2022-12-12
Published Date :2022-05-02
Published Date :2022-05-01
Published Date :2022-05-06
Published Date :2022-05-11
Published Date :2022-05-13
Published Date :2022-05-04
Published Date :2022-05-07
Published Date :2022-05-08
Published Date :2022-05-09
Published Date :2022-05-09
Published Date :2022-05-06
Published Date :2022-05-13
Published Date :2022-05-10
Published Date :2022-05-12
Published Date :2022-05-10
Published Date :2022-05-13